Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 6, 2006, Pages 477-488

  Lankveld, D P K ^b   Driessen, B ^a   Soma, L R ^a   Moate, P J ^a   Rudy, J ^c   Uboh, C E ^a,c   Van Dijk, P ^b   Hellebrekers, L J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c WEST CHESTER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DEHYDRONORKETAMINE; DRUG METABOLITE; ENZYME; FATTY ACID; GLUCOSE; HYDROCORTISONE; HYDROXYNORKETAMINE; INSULIN; KETAMINE; LACTIC ACID; NARKETAN; NORKETAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTERIAL GAS; ARTICLE; BREATHING; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HORSE; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; MUSCLE TONE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SEDATION; TANDEM MASS SPECTROMETRY;

ANALGESICS; ANIMALS; AREA UNDER CURVE; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; DRUG ADMINISTRATION SCHEDULE; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART RATE; HORSES; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; INSULIN; KETAMINE; LACTIC ACID; MALE; MUSCLE, SKELETAL;

EQUIDAE; EQUUS CABALLUS;

EID: 33750582242     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00794.x     Document Type: Article

References (53)

1. Baggot, J.D. & Blake, J.W. (1976) Disposition kinetics of ketamine in the domestic cat. Archives Internationales de Pharmacodynamie et de Therapie, 220, 115-124.
2. Boston, R.C., Greif, P.C. & Berman, M. (1981) Conversational SAAM - an interactive program for kinetic analysis of biological systems. Computer Methods and Programs in Biomedicine, 13, 111-119.
3. Castroman, P.J. & Ness, T.J. (2002a) Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder. Anesthesiology, 96, 1401-1409.
4. Castroman, P.J. & Ness, T.J. (2002b) Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladder. Anesthesiology, 96, 1410-1419.
5. Coderre, T.J., Katz, J., Vaccarinou, A.L. & Melzack, R. (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain, 52, 259-285.
6. Delatour, P., Jaussaud, P., Courtot, D. & Fau, D. (1991) Enantioselective N-demethylation of ketamine in the horse. Journal of Veterinary Pharmacology and Therapeutics, 14, 209-212.
7. Domino, E.F., Zsigmond, E.K., Domino, L.E., Domino, K.E., Kothary, S.P. & Domino, S.E. (1982) Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentaographic assay. Anesthesia Analgesia, 61, 87-92.
8. Edwards, S.R. & Mather, L.E. (2001) Tissue uptake of ketamine and norketamine enantiomers in the rat - indirect evidence for extrahepatic metabolic inversion. Life Sciences, 69, 2051-2066.
9. Edwards, S.R., Minto, C.F. & Mather, L.E. (2002) Concurrent ketamine and alfentanil administration: pharmacokinetic considerations. British Journal of Anaesthesia, 88, 94-100.
10. Fisher, K., Coderre, T.J. & Hagen, N. (2000) Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. Journal of Pain and Symptom Management, 20, 358-373.
11. Geisslinger, G., Hering, W., Thomann, P., Knoll, R., Kamp, H.-D. & Brine, K. (1993) Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. British Journal of Anaesthesia, 70, 666-671.
12. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York.
13. Gómez de Segura, I.A., DeRossi, R., Santos, M., López San-Roman, J. & Tendillo, F.J. (1998) Epidural injection of ketamine for perineal analgesia in the horse. Journal of Veterinary Anaesthesia, 27, 384-391.
14. Guirimand, F., Dupont, X., Brasseur, L., Chauvin, M. & Bouhassira, D. (2000) The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans. Anesthesia Analgesia, 90, 408-414.
15. Hijazi, Y., Bolon, M. & Boulieu, R. (2001) Stability of ketamine and its metabolites norketamine and dehydronorketamine in human biological samples. Clinical Chemistry, 47, 1713-1715.
16. Hocking, G. & Cousins, M.J. (2003) Ketamine in chronic pain management: an evidence-based review. Anesthesia Analgesia, 97, 1730-1739.
17. Hughes, A.M., Rhodes, J., Fisher, G., Sellers, M. & Growcott, J.W. (2002) Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers. British Journal of Clinical Pharmacology, 53, 604-612.
18. Irvine, C.H. & Alexander, S.L. (1994) Factors affecting the circadian rhythm in plasma cortisol concentrations in the horse. Domestic Animal Endocrinology, 11, 227-238.
19. Kaka, J.S. & Hayton, W.L. (1980) Pharmacokinetics of ketamine and two metabolites in the dog. Journal of Pharmacokinetics and Biopharmaceutics, 8, 193-202.
20. Kaka, J.S., Klavano, P.A. & Hayton, W.L. (1979) Pharmacokinetics of ketamine in the horse. American Journal of Veterinary Research, 50, 978-981.
21. Kerr, C.L., McDonell, W. & Young, S.S. (1996) A comparison of romifidine and xylazine when used with diazepam/ketamine for short duration anesthesia in the horse. Canadian Veterinary Journal, 37, 601-609.
22. Koga, K., Ogata, M., Takenaka, I., Matsumoto, T. & Shigematsu, A. (1994) Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan sensitized endotoxin shock model. Circulatory Shock, 44, 160-168.
23. Lankveld, D.P.K., Bull, S., Van Dijk, P., Fink-Gremmels, J. & Hellebrekers, L. (2005) Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line. Veterinary Research, 36, 257-262.
24. Laurido, C., Pelissier, T., Perez, H., Flores, F. & Hernandez, A. (2001) Effect of ketamine on spinal cord nociceptive transmission in normal and monoarthritic rats. Neuroreport, 12, 1551-1554.
25. Livingston, A. & Waterman, A.E. (1978) The development of tolerance to ketamine in rats and the significance of hepatic metabolism. British Journal of Pharmacology, 64, 63-69.
26. MacKay, R.J., Merritt, M., Zertuche, J.M., Whittington, M. & Skelly, L.A. (1991) MTumor necrosis factor activity in the circulation of horses given endotoxins. American Journal of Veterinary Research, 52, 533-538.
27. Mazar, J., Rogachev, B., Shaked, G., Ziv, N.Y., Czeiger, D., Chaimovitz, C., Zlotnik, M., Mukmenev, I. & Byk, G. (2005) Involvement of adenosine in the antiinflammatory action of ketamine. Anesthesiology, 102, 1174-1181.
28. Moore, K.A., Sklerov, J., Levine, B. & Jacobs, A.J. (2001) Urine concentrations of ketamine and norketamine following illegal consumption. Journal of Analytical Toxicology, 25, 583-588.
29. Morris, D.D., Crowe, N. & Moldawer, L.L. (1992) Effect of experimentally induced endotoxemia on serum interleukin-6 activity in horses. American Journal of Veterinary Research, 53, 753-756.
30. Muir, W.W. & Sams, R. (1992) Effects of ketamine infusion on halothane minimal alveolar concentration in horses. American Journal of Veterinary Research, 53, 1802-1806.
31. Muir, W.W., Skarda, R.T. & Milne, D.W. (1977) Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses. American Journal of Veterinary Research, 38, 195-201.
32. Nolan, A., Reid, J., Welsh, E., Flaherty, D., McCormack, R. & Monteiro, A.M. (1996) Simultaneous infusions of propofol and ketamine in ponies premedicated with detomidine: a pharmacokinetic study. Research in Veterinary Science, 60, 262-266.
33. Quian, J., Brown, S.D. & Carlton, S.M. (1996) Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Research, 715, 51-62.
34. Sams, R. & Pizzo, P. (1987) Detection and identification of ketamine and its metabolites in horse urine. Journal of Analytical Toxicology, 11, 58-62.
35. Schmid, R.L., Sandler, A.N. & Katz, J. (1999) Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain, 82, 111-125.
36. Schwieger, I.M., Szlam, F. & Hug, C.C., Jr (1991) The pharmacokinetics and pharmacodynamics of ketamine in dogs anesthetized with enflurane. Journal of Pharmacokinetics and Biopharmaceutics, 19, 145-156.
37. Seay, S.S., Aucoin, D.P. & Tyczkowska, K.L. (1993) Rapid high-performance liquid chromatographic method for the determination of ketamine and its metabolite dehydronorketamine in equine serum. Journal of Chromatography, 620, 281-287.
38. Stefanovski, D., Moate, P.J. & Boston, R.C. (2003) WinSAAM: a windows-based compartmental modeling system. [Review] [18 refs]. Metabolism: Clinical & Experimental, 52, 1153-1166.
39. Strigo, I.A., Duncan, G.H., Bushnell, C., Boivin, M., Wainer, I., Rosas, E.R. & Persson, J. (2005) The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects. Pain, 113, 255-264.
40. Suzuki, R., Matthews, E.A. & Dickenson, A.H. (2001) Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy. Pain, 91, 101-109.
41. Taniguchi, T., Shibata, K. & Yamamoto, K. (2001) Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology, 95, 928-932.
42. Taniguchi, T., Takemoto, Y., Kanakura, H. & Yamamoto, K. (2003) The dose-related effects of ketamine on mortality and cytokine responses to endotoxin-induced shock in rats. Anesthesia Analgesia, 97, 1769-1772.
43. Taniguchi, T., Kanakura, H., Takemoto, Y. & Yamamoto, K. (2004) The antiinflammatory effects of ketamine in endotoxemic rats during moderate and mild hypothermia. Anesthesia Analgesia, 98, 1114-1120.
44. Van der Kolk, J.H., Wensing, T., Kalsbeek, H.C. & Breukink, H.J. (1995) Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domestic Animal Endocrinology, 12, 35-39.
45. Wagner, J.G. (1974) A safe method for rapidly achieving plasma cconcentration plateaus. Clinical Pharmacology and Therapeutics, 16, 691-700.
46. Wang, Y., Huang, C., Cao, Y. & Han, J.S. (2000) Repeated administration of low dose ketamine for the treatment of monoarthritic pain in the rat. Life Sciences, 67, 261-267.
47. Wastney, M.E., Patterson, B.H., Linares, O.A., Greif, P.C. & Boston, R.C. (1999) Investigating Biological Systems Using Modeling: Strategies and Software. 129 pp. Academic Press, New York.
48. Waterman, A. & Livingston, A. (1978) Studies on the distribution and metabolism of ketamine in sheep. Journal of Veterinary Pharmacology and Therapeutics, 1, 141-147.
49. Waterman, A.E., Robertson, S.A. & Lane, J.G. (1987) The pharmacokinetics of intravenously administered ketamine in the horse. Research in Veterinary Science, 42, 161-166.
50. White, P.F., Way, W.L. & Trevor, A.J. (1982) Ketamine its pharmacology and therapeutic uses. Anesthesiology, 56, 119-136.
51. Woolf, C.J. & Thompson, S.W. (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain, 44, 293-299.
52. Wright, M. (1982) Pharmacologic effects of ketamine in veterinary medicine. Journal of the American Veterinary Medical Association, 180, 1462-1471.
53. Zahler, S., Heindl, B. & Becker, B.F. (1999) Ketamine does not inhibit inflammatory responses of cultured human endothelial cells but reduces chemotactic activation of neutrophils. Acta Anaesthesiologica Scandinavica, 43, 1011-1016.